Magnetoencephalography in Children

ConditionsEpilepsy Intracranial Tumors Cerebrovascular Disease Autism ADHD - Attention Deficit Disorder With Hyperactivity Neuropsychiatric Disorders Tic Disorder, Childhood Mental Retardation Developmental Disabilities

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-18

SponsorChildren's Hospital of Fudan University

About this trial

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

aged 1 month-18 years old (date of investigate minus date of birth)

epilepsy

intracranial tumors

cerebrovascular diseases

Disqualifiers

None

Trial population

Children aged 1 month to 18 years old

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Magnetoencephalography
Other intervention
Magnetoencephalography

Treatment groups

1,500 Participants

are divided into 2 treatment groups

Group A: children with neurodevelopmental diseases1 intervention

Group B: healthy children1 intervention

Trial outcomes

Primary outcomes

Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children

Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria

Time frame

3 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Children's Hospital of Fudan University

Lead sponsor

Source ClinicalTrials.gov

Apply now